{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:51:06Z","timestamp":1791049866873,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T00:00:00Z","timestamp":1329868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s12017-012-8174-1","type":"journal-article","created":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T12:17:55Z","timestamp":1329826675000},"page":"84-90","source":"Crossref","is-referenced-by-count":46,"title":["Coenzyme Q10, Hyperhomocysteinemia and MTHFR C677T Polymorphism in Levodopa-treated Parkinson\u2019s Disease Patients"],"prefix":"10.1007","volume":"14","author":[{"given":"Gaetano","family":"Gorgone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Curr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ferlazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Parnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Belcastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Tambasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroldo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Ientile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Caccamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,22]]},"reference":[{"key":"8174_CR1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.2003.tb07470.x","volume":"991","author":"MF Beal","year":"2003","unstructured":"Beal, M. F. (2003). Mitochondria, oxidative damage, and inflammation in Parkinson\u2019s disease. Annals of the New York Academy of Science, 991, 120\u2013131.","journal-title":"Annals of the New York Academy of Science"},{"key":"8174_CR2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1385\/NMM:6:2-3:117","volume":"6","author":"D Caccamo","year":"2004","unstructured":"Caccamo, D., Condello, S., Gorgone, G., Crisafulli, G., Belcastro, V., Gennaro, S., et al. (2004). Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia. Neuromolecular Medicine, 6, 117\u2013126.","journal-title":"Neuromolecular Medicine"},{"key":"8174_CR3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12017-007-8006-x","volume":"9","author":"D Caccamo","year":"2007","unstructured":"Caccamo, D., Gorgone, G., Curr\u00f2, M., Parisi, G., Di Iorio, W., Menichetti, C., et al. (2007). Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated parkinsonian patients. Neuromolecular Medicine, 9, 249\u2013254.","journal-title":"Neuromolecular Medicine"},{"issue":"1","key":"8174_CR4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1471-4159.2010.06924.x","volume":"115","author":"D Cartelli","year":"2010","unstructured":"Cartelli, D., Ronchi, C., Maggioni, M. G., Rodighiero, S., Giavini, E., & Cappelletti, G. (2010). Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+-induced neurodegeneration. Journal of Neurochemistry, 115(1), 247\u2013258.","journal-title":"Journal of Neurochemistry"},{"key":"8174_CR5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1017\/S0007114500000751","volume":"83","author":"A Chango","year":"2000","unstructured":"Chango, A., Boisson, F., Barbe, F., Quilliot, D., Droesch, S., Pifster, M., et al. (2000). The effect of 677CT and 1298AC mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. British Journal of Nutrition, 83, 593\u2013596.","journal-title":"British Journal of Nutrition"},{"key":"8174_CR6","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.freeradbiomed.2006.08.002","volume":"41","author":"SJ Chinta","year":"2006","unstructured":"Chinta, S. J., & Andersen, J. K. (2006). Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson\u2019s disease. Free Radical Biology and Medicine, 41, 1442\u20131448.","journal-title":"Free Radical Biology and Medicine"},{"issue":"1","key":"8174_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1471-4159.2010.07085.x","volume":"116","author":"S Condello","year":"2011","unstructured":"Condello, S., Curr\u00f2, M., Ferlazzo, N., Caccamo, D., Satriano, J., & Ientile, R. (2011). Agmatine effects on mitochondrial membrane potential andNF-\u03baB activation protect against rotenone-induced cell damage in human neuronal-like SH-SY5Y cells. Journal of Neurochemistry, 116(1), 67\u201375.","journal-title":"Journal of Neurochemistry"},{"key":"8174_CR8","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.1523\/JNEUROSCI.1947-08.2008","volume":"28","author":"C Costa","year":"2008","unstructured":"Costa, C., Belcastro, V., Tozzi, A., Di Filippo, M., Tantucci, M., Siliquini, S., et al. (2008). Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. Journal of Neuroscience, 28, 8040\u20138052.","journal-title":"Journal of Neuroscience"},{"issue":"6","key":"8174_CR9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ana.20509","volume":"57","author":"LM Lau de","year":"2005","unstructured":"de Lau, L. M., Koudstaal, P. J., van Meurs, J. B., Uitterlinden, A. G., Hofman, A., & Breteler, M. M. (2005). Methylenetetrahydrofolate reductase C677T genotype and PD. Annals of Neurology, 57(6), 927\u2013930.","journal-title":"Annals of Neurology"},{"key":"8174_CR10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.0022-3042.2001.00676.x","volume":"80","author":"W Duan","year":"2002","unstructured":"Duan, W., Ladenheim, B., Cutler, R. G., Kruman, I. I., Cadet, J. L., & Mattson, M. P. (2002). Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson\u2019s disease. Journal of Neurochemistry, 80, 101\u2013110.","journal-title":"Journal of Neurochemistry"},{"key":"8174_CR11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1471-4159.2005.03638.x","volume":"96","author":"M Fasano","year":"2006","unstructured":"Fasano, M., Bergamasco, B., & Lopiano, L. (2006). Modifications of the iron-neuromelanin system in Parkinson\u2019s disease. Journal of Neurochemistry, 96, 909\u2013916.","journal-title":"Journal of Neurochemistry"},{"key":"8174_CR12","doi-asserted-by":"crossref","unstructured":"Galpern, W. R., & Cudkowicz, M. E. (2007). Coenzyme Q treatment of neurodegenerative diseases of aging. Mitochondrion, 7, S146\u2013S153.","DOI":"10.1016\/j.mito.2007.01.004"},{"key":"8174_CR13","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1093\/brain\/awh584","volume":"128","author":"GM Halliday","year":"2005","unstructured":"Halliday, G. M., Ophof, A., Broe, M., Jensen, P. H., Kettle, E., Fedorow, H., et al. (2005). Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson\u2019s disease. Brain, 128, 2654\u20132664.","journal-title":"Brain"},{"key":"8174_CR14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuint.2003.11.018","volume":"45","author":"A Hermida-Ameijeiras","year":"2004","unstructured":"Hermida-Ameijeiras, A., Mendez-Alvarez, E., Sanchez-Iglesias, S., Sanmartin-Suarez, C., & Soto-Otero, R. (2004). Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: Role of ferrous and ferric ions. Neurochemistry International, 45, 103\u2013116.","journal-title":"Neurochemistry International"},{"key":"8174_CR15","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.42.6.1142","volume":"42","author":"AJ Hughes","year":"1992","unstructured":"Hughes, A. J., Ben-Shlomo, Y., Daniel, S. E., & Lees, A. J. (1992). What features improve the accuracy of clinical diagnosis in Parkinson\u2019s disease? A clinicopathologic study. Neurology, 42, 1142\u20131146.","journal-title":"Neurology"},{"key":"8174_CR16","doi-asserted-by":"crossref","unstructured":"Isobe, C., Abe, T., & Terayama, Y. (2010). Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2\u2019-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson\u2019s disease demonstrate that mitochondrial oxidative damage and\/or oxidative DNA damage contributes to the neurodegenerative process. Neuroscience Letters, 469, 159\u2013163.","DOI":"10.1016\/j.neulet.2009.11.065"},{"key":"8174_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007020050001","volume":"107","author":"KA Jellinger","year":"2000","unstructured":"Jellinger, K. A. (2000). Cell death mechanisms in Parkinson\u2019s disease. Journal of Neural Transmission, 107, 1\u201329.","journal-title":"Journal of Neural Transmission"},{"key":"8174_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mds.20261","volume":"20","author":"P Lamberti","year":"2005","unstructured":"Lamberti, P., Zoccolella, S., Iliceto, G., Armenise, E., Fraddosio, A., de Mari, M., et al. (2005). Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson\u2019s disease patients. Movement Disorders, 20, 69\u201372.","journal-title":"Movement Disorders"},{"key":"8174_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","volume":"26","author":"MP Mattson","year":"2003","unstructured":"Mattson, M. P., & Shea, T. B. (2003). Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends in Neuroscience, 26, 137\u2013146.","journal-title":"Trends in Neuroscience"},{"issue":"10","key":"8174_CR20","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1373\/clinchem.2009.125021","volume":"55","author":"R Obeid","year":"2009","unstructured":"Obeid, R., Schadt, A., Dillmann, U., Kostopoulos, P., Fassbender, K., & Herrmann, W. (2009). Methylation status and neurodegenerative markers in Parkinson disease. Clinical Chemistry, 55(10), 1852\u20131860.","journal-title":"Clinical Chemistry"},{"issue":"2","key":"8174_CR21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.parkreldis.2005.10.002","volume":"12","author":"PE O\u2019Suilleabhain","year":"2006","unstructured":"O\u2019Suilleabhain, P. E., Oberle, R., Bartis, C., Dewey, R. B., Jr., Bottiglieri, T., & Diaz-Arrastia, R. (2006). Clinical course in Parkinson\u2019s disease with elevated homocysteine. Parkinsonism Related Disorders, 12(2), 103\u2013107.","journal-title":"Parkinsonism Related Disorders"},{"key":"8174_CR22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.61.6.865","volume":"61","author":"PE O\u2019Suilleabhain","year":"2004","unstructured":"O\u2019Suilleabhain, P. E., Sung, V., Hernandez, C., Lacritz, L., Dewey, R. B., Jr., Bottiglieri, T., et al. (2004). Elevated plasma homocysteine level in patients with Parkinson disease: Motor, affective, and cognitive associations. Archives of Neurology, 61, 865\u2013868.","journal-title":"Archives of Neurology"},{"key":"8174_CR23","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1074\/jbc.M401135200","volume":"279","author":"JJ Palacino","year":"2004","unstructured":"Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., et al. (2004). Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. Journal of Biological Chemistry, 279, 18614\u201318622.","journal-title":"Journal of Biological Chemistry"},{"key":"8174_CR24","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.WNL.0000137886.74175.5A","volume":"63","author":"RB Postuma","year":"2004","unstructured":"Postuma, R. B., & Lang, A. E. (2004). Homocysteine and levodopa. Should Parkinson disease patients receive preventative therapy? Neurology, 63, 886\u2013891.","journal-title":"Neurology"},{"issue":"1","key":"8174_CR25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2006.01.013","volume":"23","author":"A Prigione","year":"2006","unstructured":"Prigione, A., Begni, B., Galbussera, A., Beretta, S., Brighina, L., Garofalo, R., et al. (2006). Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson\u2019s disease: negative correlation with levodopa dosage. Neurobiological Disease, 23(1), 36\u201343.","journal-title":"Neurobiological Disease"},{"issue":"22","key":"8174_CR26","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1212\/WNL.0b013e31823a0ee4","volume":"77","author":"YA Rajabally","year":"2011","unstructured":"Rajabally, Y. A., & Martey, J. (2011). Neuropathy in Parkinson disease: Prevalence and determinants. Neurology, 77(22), 1947\u20131950.","journal-title":"Neurology"},{"issue":"5","key":"8174_CR27","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1086\/301836","volume":"62","author":"JA Schneider","year":"1998","unstructured":"Schneider, J. A., Rees, D. C., Liu, Y. T., & Clegg, J. B. (1998). Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. American Journal of Human Genetics, 62(5), 1258\u20131260.","journal-title":"American Journal of Human Genetics"},{"key":"8174_CR28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ana.410420221","volume":"42","author":"CW Shults","year":"1997","unstructured":"Shults, C. W., Haas, R. H., Passov, D., & Beal, M. F. (1997). Coenzyme Q10 levels correlate with the activities of the complex I and II\/III in mitochondria from parkinsonian and nonparkinsonian subjects. Annals of Neurology, 42, 261\u2013264.","journal-title":"Annals of Neurology"},{"key":"8174_CR29","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","volume":"59","author":"CW Shults","year":"2002","unstructured":"Shults, C. W., Oakes, D., Kieburtz, K., et al. (2002). Effects of coenzyme Q-sub-1-sub-0 in early Parkinson disease: Evidence of slowing of the functional decline. Arch Neurology, 59, 1541\u20131550.","journal-title":"Arch Neurology"},{"key":"8174_CR30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jns.2004.05.007","volume":"223","author":"M Sohmiya","year":"2004","unstructured":"Sohmiya, M., Tanaka, M., Tak, N. W., Yanagisawa, M., Tanino, Y., Suzuki, Y., et al. (2004). Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson\u2019s disease. Journal of Neurological Sciences, 223, 161\u2013166.","journal-title":"Journal of Neurological Sciences"},{"issue":"4\u20135","key":"8174_CR31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0161-813X(02)00060-8","volume":"23","author":"SE Stephans","year":"2002","unstructured":"Stephans, S. E., Miller, G. W., Levey, A. I., & Greenamyre, J. T. (2002). Acute mitochondrial and chronic toxicological effects of 1-methyl-4-phenylpyridinium in human neuroblastoma cells. Neurotoxicology, 23(4\u20135), 569\u2013580.","journal-title":"Neurotoxicology"},{"issue":"7","key":"8174_CR32","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archneur.64.7.nct60005","volume":"64","author":"A Storch","year":"2007","unstructured":"Storch, A., Jost, W. H., Vieregge, P., et al. (2007). (2007) Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q10 in Parkinson disease. Arch Neurology, 64(7), 938\u2013944.","journal-title":"Arch Neurology"},{"key":"8174_CR33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jns.2006.05.040","volume":"248","author":"Z Todorovic","year":"2006","unstructured":"Todorovic, Z., Dzoljic, E., Novakovic, I., Mirkovi\u0107, D., Stojanovi\u0107, R., Nesi\u0107, Z., et al. (2006). Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson\u2019s disease, with and without levodopa therapy. Journal of Neurological Sciences, 248, 56\u201361.","journal-title":"Journal of Neurological Sciences"},{"key":"8174_CR34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/abio.1997.2187","volume":"250","author":"S Yamashita","year":"1997","unstructured":"Yamashita, S., & Yamamoto, Y. (1997). Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Analytical Biochemistry, 250, 66\u201373.","journal-title":"Analytical Biochemistry"},{"issue":"8","key":"8174_CR35","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/NEN.0b013e3182269ecd","volume":"70","author":"T Yasuda","year":"2011","unstructured":"Yasuda, T., Hayakawa, H., Nihira, T., Ren, Y. R., Nakata, Y., Nagai, M., et al. (2011). Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease. Journal of Neuropathology and Experimental Neurology, 70(8), 686\u2013697.","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"8174_CR36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1212\/WNL.55.3.437","volume":"55","author":"K Yasui","year":"2000","unstructured":"Yasui, K., Kowa, H., Nakaso, K., Takeshima, T., & Nakashima, K. (2000). Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD. Neurology, 55, 437\u2013440.","journal-title":"Neurology"},{"key":"8174_CR37","doi-asserted-by":"crossref","unstructured":"Young, A. J., Johnson, S., Steffens, D. C., & Doraiswamy, P. M. (2007, Jan). Coenzyme Q10: A review of its promise as a neuroprotectant. CNS Spectr, 12(1), 62\u201368.","DOI":"10.1017\/S1092852900020538"},{"key":"8174_CR38","doi-asserted-by":"crossref","unstructured":"Zoccolella, S., dell\u2019Aquila, C., Abruzzese, G., Antonini, A., Bonuccelli, U., Canesi, M., et al. (2009). Hyperhomocysteinemia in levodopa-treated patients with Parkinson\u2019s disease dementia. Movement Disorders, 24(7), 1028\u20131033.","DOI":"10.1002\/mds.22511"},{"key":"8174_CR39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/ars.2005.7.547","volume":"7","author":"CG Zou","year":"2005","unstructured":"Zou, C. G., & Banerjee, R. (2005). Homocysteine and redox signaling. Antioxidants & Redox Signaling, 7, 547\u2013559.","journal-title":"Antioxidants & Redox Signaling"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-012-8174-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-012-8174-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-012-8174-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T01:45:47Z","timestamp":1561340747000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-012-8174-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,22]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["8174"],"URL":"https:\/\/doi.org\/10.1007\/s12017-012-8174-1","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,22]]}}}